• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reporting of Racial and Ethnic Minority Representation in Early Phase Pediatric Oncology Clinical Trials.报告儿科肿瘤早期临床试验中的种族和少数民族代表性。
Oncologist. 2022 Aug 5;27(8):e681-e682. doi: 10.1093/oncolo/oyac124.
2
Reporting of Participant Race and Ethnicity in Published US Pediatric Clinical Trials From 2011 to 2020.报告 2011 年至 2020 年美国儿科临床试验中参与者的种族和民族情况。
JAMA Pediatr. 2022 May 1;176(5):e220142. doi: 10.1001/jamapediatrics.2022.0142. Epub 2022 May 2.
3
Declining Representation and Reporting of Racial and Ethnic Minority Patients in Prostate Cancer Clinical Trials Despite Persistent Health Disparities-Where Progress Confronts Limitations.尽管存在持续的健康差距，但在前列腺癌临床试验中，少数族裔患者的代表性和报告率仍在下降——进步面临局限。
JAMA Oncol. 2023 Feb 1;9(2):175-177. doi: 10.1001/jamaoncol.2022.6749.
4
Reporting and Representation of Participant Race and Ethnicity in National Institutes of Health-Funded Pediatric Clinical Trials.报告和代表参与者的种族和民族在国立卫生研究院资助的儿科临床试验。
JAMA Netw Open. 2023 Aug 1;6(8):e2331316. doi: 10.1001/jamanetworkopen.2023.31316.
5
Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review.老年患者、女性以及种族和少数民族个体在心脏瓣膜病临床试验中的入组情况：一项系统评价。
JAMA Cardiol. 2023 Sep 1;8(9):871-878. doi: 10.1001/jamacardio.2023.2098.
6
Review of Racial and Ethnic Representation of Participants Enrolled in Pediatric Clinical Trials of Oncology Drugs Conducted Through FDA Written Requests.通过 FDA 书面请求开展的肿瘤药物儿科临床试验中入组参与者的种族和民族代表性回顾。
JAMA Oncol. 2024 Mar 1;10(3):380-383. doi: 10.1001/jamaoncol.2023.5781.
7
A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016.2002-2016 年在美国开展的 HVTN 预防早期阶段 HIV 疫苗临床试验中，对少数族裔入组的人口统计学分析。
Public Health Rep. 2019 Jan/Feb;134(1):72-80. doi: 10.1177/0033354918814260. Epub 2018 Dec 5.
8
Racial and ethnic minority participants in clinical trials of acute respiratory distress syndrome.急性呼吸窘迫综合征临床试验中的种族和少数民族参与者。
Intensive Care Med. 2023 Dec;49(12):1479-1488. doi: 10.1007/s00134-023-07238-x. Epub 2023 Oct 17.
9
Geographic disparities in utilization of living donor liver transplants for racial and ethnic minorities in the United States.美国种族和少数民族活体供肝移植利用情况的地理差异。
Liver Transpl. 2023 Dec 1;29(12):1337-1339. doi: 10.1097/LVT.0000000000000193. Epub 2023 Jun 29.
10
Recent Trends in School-Based Mental Health Services Among Low-Income and Racial and Ethnic Minority Adolescents.低收入和少数族裔青少年学校心理健康服务的最新趋势。
JAMA Pediatr. 2022 Aug 1;176(8):813-815. doi: 10.1001/jamapediatrics.2022.1020.

本文引用的文献

1
Advancing the inclusion of underrepresented women in clinical research.推动代表性不足的女性参与临床研究。
Cell Rep Med. 2022 Mar 7;3(4):100553. doi: 10.1016/j.xcrm.2022.100553. eCollection 2022 Apr 19.
2
Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials.临床试验中的种族和民族代表性：一项 I 期肿瘤学试验文献回顾的结果。
Future Oncol. 2021 Aug;17(24):3271-3280. doi: 10.2217/fon-2020-1262. Epub 2021 May 28.
3
Acute lymphoblastic leukemia mortality in Hispanic Americans.美籍西班牙裔人群中急性淋巴细胞白血病的死亡率。
Leuk Lymphoma. 2020 Nov;61(11):2674-2681. doi: 10.1080/10428194.2020.1779260. Epub 2020 Jun 22.
4
A Literature Review of Racial Disparities in Overall Survival of Black Children With Acute Lymphoblastic Leukemia Compared With White Children With Acute Lymphoblastic Leukemia.与患急性淋巴细胞白血病的白人儿童相比，患急性淋巴细胞白血病的黑人儿童总生存率种族差异的文献综述。
J Pediatr Oncol Nurs. 2020 May/Jun;37(3):180-194. doi: 10.1177/1043454220907547. Epub 2020 Feb 24.
5
A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies.儿科肿瘤学 I 期临床试验的系统评价：靶向治疗时代的毒性和结局。
Oncologist. 2020 Jun;25(6):532-540. doi: 10.1634/theoncologist.2019-0615. Epub 2020 Jan 14.
6
A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking.一项探索临床试验和生物样本库中纳入代表性不足人群的障碍与促进因素的定性研究。
Front Cell Dev Biol. 2019 Apr 30;7:74. doi: 10.3389/fcell.2019.00074. eCollection 2019.

报告儿科肿瘤早期临床试验中的种族和少数民族代表性。

Reporting of Racial and Ethnic Minority Representation in Early Phase Pediatric Oncology Clinical Trials.

机构信息

Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.

Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.

出版信息

Oncologist. 2022 Aug 5;27(8):e681-e682. doi: 10.1093/oncolo/oyac124.

DOI:10.1093/oncolo/oyac124
PMID:35791896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9355810/
Abstract

This letter to the editor considers outcomes for underrepresented populations across early phase pediatric oncology clinical trials, considering barriers to equitable representation of minorities in clinical trials.

摘要

这封给编辑的信考虑了儿科肿瘤早期临床试验中代表性不足的人群的结果，同时考虑了少数族裔在临床试验中公平代表的障碍。